Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Neutra's operating cash flow for the twelve months ending Oct 31, 2023 was -$9.76K. For fiscal 2023 it was -$153.24K. The highest annual figure on record is -$68.25K in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | -$153.24K | – |
| FY2022 | Jan 31, 2022 | -$405.62K | – |
| FY2021 | Jan 31, 2021 | -$412.38K | – |
| FY2020 | Jan 31, 2020 | -$181.61K | – |
| FY2019 | Jan 31, 2019 | -$417.00K | – |
| FY2018 | Jan 31, 2018 | -$108.93K | – |
| FY2017 | Jan 31, 2017 | -$211.62K | – |
| FY2016 | Jan 31, 2016 | -$491.72K | – |
| FY2015 | Jan 31, 2015 | -$546.54K | – |
| FY2014 | Jan 31, 2014 | -$800.05K | – |
| FY2013 | Jan 31, 2013 | -$244.73K | – |
| FY2012 | Jan 31, 2012 | -$68.25K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$442 | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$2.00K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$8.83K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $1.51K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$23.23K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$38.86K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$92.67K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$53.00K | – |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | -$148.56K | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | -$102.31K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$101.74K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$209.20K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$79.00K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$76.77K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$47.41K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$112.82K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$50.00K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$135.00K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$139.50K | -2625.3% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $0 | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$142.50K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $0 | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $5.52K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$44.20K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$70.25K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$16.55K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$4.63K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$66.52K | – |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | -$123.92K | – |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | -$108.07K | – |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | -$260.22K | – |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | -$56.25K | – |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | -$67.18K | – |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | -$89.60K | – |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | -$105.06K | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | -$193.40K | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | -$158.48K | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | -$144.17K | – |
See a number that looks wrong?